⌘K

Login Start Free

Home/Filings/4/0001169245-21-000103

4//SEC Filing

Sharp John P 4

Accession 0001169245-21-000103

CIK 0001169245other

View on SEC.gov Company Profile

Filed

Nov 2, 8:00 PM ET

Accepted

Nov 3, 7:30 PM ET

Size

6.8 KB

Accession

0001169245-21-000103

Insider Transaction Report

Form 4

Period: 2021-11-03

PhaseBio Pharmaceuticals IncPHAS

CFO and Secretary

Transactions

Exercise/Conversion
Employee Stock Option (right to buy)
2021-11-03$1.68/sh−7,500$12,600→ 90,582 total
Exercise: $1.68From: 2020-04-11Exp: 2026-05-12→ Common Stock (7,500 underlying)
Exercise/Conversion
Common Stock
2021-11-03$1.68/sh+7,500$12,600→ 57,724 total

Footnotes (1)

[F1]All shares underlying this option have vested.

Documents

1 file

4
wf-form4_163598221793336.xmlPrimary
FORM 4

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1

filerCIK 0001342894

Filing Metadata

Form type: 4
Filed: Nov 2, 8:00 PM ET
Accepted: Nov 3, 7:30 PM ET
Size: 6.8 KB

View on SEC.gov